Preliminary results of multicenter studies on ABO-incompatible kidney transplantation
蒋鸿涛,李涛,任坤,于小华,王毅,张善斌,李德胜,甘惠玲,刘厚琴,徐亮,罗志刚,桂培根,谭湘芳,石炳毅,蔡明,李响,徐俊楠,许亮,林涛,王显丁,刘洪涛,张乐希,吴建永,雷文华,邱江,陈国栋,李军,黄刚,吴成林,王长希,陈立中,陈正,方佳丽,张晓明,门同义,李现铎,莫春柏,王振,史晓峰,裴广辉,涂金鹏,胡小鹏,张晓东,李宁,石韶华,陈花,王振兴,眭维国,李盈,晏强,陈怀周,赖柳生,李金锋,尚文俊,丰贵文,陈刚,曾凡军,朱兰,方军,戎瑞明,王宣传,戚贵生,王强,田普训,李杨,田晓辉,项和立,潘晓鸣,丁小明,薛武军,文吉秋,徐小松
DOI: https://doi.org/10.3760/cma.j.cn421203-20200416-00120
2020-01-01
Abstract:Objective:To summarize the patient profiles and therapeutic efficacies of ABO-incompatible living-related kidney transplantations at 19 domestic transplant centers and provide rationales for clinical application of ABOi-KT.Methods:Clinical cases of ABO-incompatible/compatible kidney transplantation (ABOi-KT/ABOc-KT) from December 2006 to December 2009 were collected. Then, statistical analyses were conducted from the aspects of tissue matching, perioperative managements, complications and survival rates of renal allograft or recipients.Results:Clinical data of 342 ABOi-KT and 779 ABOc-KT indicated that (1) no inter-group differences existed in age, body mass index (BMI), donor-recipient relationship or waiting time of pre-operative dialysis; (2) ABO blood type: blood type O recipients had the longest waiting list and transplantations from blood type A to blood type O accounted for the largest proportion; (3) HLA matching: no statistical significance existed in mismatch rate or positive rate of PRA I/II between two types of surgery; (4) CD20 should be properly used on the basis of different phrases; (5) hemorrhage was a common complication during an early postoperative period and microthrombosis appeared later; (6) no difference existed in postoperative incidence of complications or survival rate of renal allograft and recipients at 1/3/5/10 years between ABOi-KT and ABOc-KT. The acute rejection rate and serum creatinine levels of ABOi-KT recipients were comparable to those of ABOc-KT recipients within 1 year.Conclusions:ABOi-KT is both safe and effective so that it may be applied at all transplant centers as needed.